- Corporate Officers - S
- Stout Jay S
Insider Trading History of Stout Jay S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stout Jay S since 2018.
This trader's CIK number is 1702969.
At the time of last reporting, Stout Jay S was the Chief Technology Officer of Immunovant, Inc.. (stock ticker symbol IMVT).
Also see all insider trading activities at Immunovant, Inc..
Note that in the past
Stout Jay S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Immunovant, Inc. (IMVT) by Stout Jay S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | IMVT | 0 | $0 | 8,444 | $157,347 | 0 | $0 |
| 2024 | IMVT | 0 | $0 | 12,792 | $368,207 | 0 | $0 |
Yearly summary of insider trading at Aravive, Inc. (VSAR) by Stout Jay S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | VSAR | 0 | $0 | 4,854 | $7,523 | 0 | $0 |
Insider trading activities at 2 companies by Stout Jay S:
1. Immunovant, Inc. (IMVT)
2. Aravive, Inc. (VSAR)
Table 1. Insider trading of Immunovant, Inc. (IMVT) by Stout Jay S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-07-23 | IMVT | Sale | 2,805 | 18.15 | 50,910 |
| 2025-07-09 | IMVT | Sale | 1,519 | 17.24 | 26,187 |
| 2025-04-23 | IMVT | Sale | 1,925 | 14.79 | 28,470 |
| 2025-01-22 | IMVT | Sale | 2,195 | 23.59 | 51,780 |
| 2024-10-23 | IMVT | Sale | 2,740 | 29.53 | 80,912 |
| 2024-07-24 | IMVT | Sale | 2,813 | 27.76 | 78,088 |
| 2024-04-24 | IMVT | Sale | 7,239 | 28.90 | 209,207 |
Table 2. Insider trading of Aravive, Inc. (VSAR) by Stout Jay S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-04-24 | VSAR | Sale | 4,854 | 1.55 | 7,523 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Stout Jay S
(Chief Technology Officer of Immunovant, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.